VRTX has been in the news 409% more than usual
May 01, 2025, 8:32 PM
-11.40%
What does VRTX do
Vertex Pharmaceuticals, headquartered in Boston, specializes in developing small molecule drugs for serious diseases, with four approved cystic fibrosis treatments and therapies for sickle cell disease. The company employs 5,400 people and explores innovative treatments for various conditions, including type 1 diabetes.
VRTX has been in the news recently: Kintsugi AI, supported by Vertex Inc., significantly improves tax automation for businesses by reducing preparation time by 75% and compliance costs by 50%. In related news, Biogen Inc. reported a first quarter 2025 adjusted earnings per share of $3.02, which, although lower than last year's $3.67, surpassed analyst expectations of $2.52.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.